A Novel Type of Vascular Endothelial Growth Factor, VEGF-E (NZ-7 VEGF), Preferentially Utilizes KDR/Flk-1 Receptor and Carries a Potent Mitotic Activity without Heparin-binding Domain

This publication has 43 references indexed in Scilit:

• Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
  Published by Elsevier ,1996
• The Carboxyl-terminal Domain(111–165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency
  Journal of Biological Chemistry, 1996
• Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
  Nature, 1995
• Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
  Nature, 1995
• Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.
  Proceedings of the National Academy of Sciences, 1993
• Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
  Biochemical and Biophysical Research Communications, 1992
• The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
  Science, 1992
• What Is the Evidence That Tumors Are Angiogenesis Dependent?
  JNCI Journal of the National Cancer Institute, 1990
• Human Platelet-Derived Growth Factor (PDGF): Amino-Terminal Amino Acid Sequence
  Science, 1983
• THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
  Annals of the New York Academy of Sciences, 1949